Unknown

Dataset Information

0

Natively glycosylated HIV-1 Env structure reveals new mode for antibody recognition of the CD4-binding site.


ABSTRACT: HIV-1 vaccine design is informed by structural studies elucidating mechanisms by which broadly neutralizing antibodies (bNAbs) recognize and/or accommodate N-glycans on the trimeric envelope glycoprotein (Env). Variability in high-mannose and complex-type Env glycoforms leads to heterogeneity that usually precludes visualization of the native glycan shield. We present 3.5-Å- and 3.9-Å-resolution crystal structures of the HIV-1 Env trimer with fully processed and native glycosylation, revealing a glycan shield of high-mannose and complex-type N-glycans, which we used to define complete epitopes of two bNAbs. Env trimer was complexed with 10-1074 (against the V3-loop) and IOMA, a new CD4-binding site (CD4bs) antibody. Although IOMA derives from VH1-2*02, the germline gene of CD4bs-targeting VRC01-class bNAbs, its light chain lacks the short CDRL3 that defines VRC01-class bNAbs. Thus IOMA resembles 8ANC131-class/VH1-46-derived CD4bs bNAbs, which have normal-length CDRL3s. The existence of bNAbs that combine features of VRC01-class and 8ANC131-class antibodies has implications for immunization strategies targeting VRC01-like bNAbs.

SUBMITTER: Gristick HB 

PROVIDER: S-EPMC5127623 | BioStudies | 2016-01-01

REPOSITORIES: biostudies

Similar Datasets

2014-01-01 | S-EPMC4148451 | BioStudies
2018-01-01 | S-EPMC6237427 | BioStudies
2016-01-01 | S-EPMC4811768 | BioStudies
2018-11-21 | PXD011494 | Pride
2017-01-01 | S-EPMC5640423 | BioStudies
2014-01-01 | S-EPMC3932900 | BioStudies
2017-01-01 | S-EPMC5379070 | BioStudies
2019-01-01 | S-EPMC6891888 | BioStudies
2018-01-01 | S-EPMC6896779 | BioStudies
2013-01-01 | S-EPMC3954647 | BioStudies